|  |  | Number of bound regions | Overlap between antibodies for the same factor | ||
---|---|---|---|---|---|---|
Regulatory class | Factor antibody | Amino acids recognized | 1% FDR | 25% FDR | % overlap | r |
A-P early | BCD 1* | 56-330 | 619 | 3,295 | 95 | 0.79 |
maternal | BCD 2* | 330-489 | 702 | 3,404 | 93 | 0.81 |
 | CAD 1* | 1-240 | 1,591 | 6,326 | NA | NA |
A-P early gap | GT 2* | 182-353 | 1,070 | 3,968 | NA | NA |
 | HB 1* | 1-305 | 1,832 | 4,707 | 86 | 0.64 |
 | HB 2* | 306-758 | 1,718 | 6,675 | 92 | 0.80 |
 | KNI 1* | 130-280 | 36 | 330 | 97 | 0.90 |
 | KNI 2* | 281-425 | 197 | 5,167 | 83 | 0.86 |
 | KR 1* | 1-230 | 3,593 | 11,323 | 96 | 0.91 |
 | KR 2* | 350-502 | 4,084 | 12,255 | 93 | 0.93 |
A-P early terminal | HKB 1 | 1-100 | 1,012 | 5,339 | 99, 94 | 0.88, 0.64 |
 | HKB 2 | 101-200 | 614 | 4,241 | 99, 89 | 0.81, 0.34 |
 | HKB 3 | 201-297 | 638 | 3,766 | 99, 99 | 0.92, 0.99 |
 | TLL 1 | 110-259 | 429 | 2,650 | NA | NA |
A-P early gap-like | D 1 | 1-103 | 6,452 | 16,501 | NA | NA |
A-P pair rule | FTZ 3 | All | 403 | 3,721 | NA | NA |
 | HRY 1 | 123-221 | 1,704 | 6,053 | 97 | 0.80 |
 | HRY 2 | 254-337 | 2,729 | 10,979 | 80 | 0.73 |
 | PRD 1 | 355-450 | 2,061 | 7,145 | 96 | 0.93 |
 | PRD 2 | 450-613 | 1,273 | 5691 | 99 | 0.92 |
 | RUN 1 | 24-127, 240-318 | 921 | 8,809 | 77 | 0.79 |
 | RUN 2 | 319-510 | 172 | 2,903 | 99 | 0.75 |
 | SLP1 1 | 1-119 | 1,171 | 6,974 | NA | NA |
D-V maternal | DA 2 | 511-693 | 5,534 | 14,144 | NA | NA |
 | DL 3 | All | 9,358 | 18,113 | NA | NA |
D-V zygotic | MAD 2 | 144-254 | 204 | 10,969 | NA | NA |
 | MED 2 | 385-523, 630-713 | 5,458 | 9,273 | NA | NA |
 | SHN 2 | 1617-1750 | 341 | 1,400 | 47 | 0.70 |
 | SHN 3 | 2115-2279 | 121 | 363 | 87 | 0.38 |
 | SNA 1 | 75-166 | 596 | 4,868 | 100 | 0.87 |
 | SNA 2 | 167-258 | 2,800 | 15,811 | 61 | 0.82 |
 | TWI 1 | 1-178 | 6,686 | 17,486 | 99 | 0.98 |
 | TWI 2 | 259-363 | 7,416 | 19,605 | 98 | 0.98 |
General | Pol II H14* | CTD | 3,108 | 7,991 | NA | NA |
 | TFIIB | All | 1,943 | 6,002 | NA | NA |